ProBioGen gains operational control of Berlin’s advanced therapy manufacturing hub
German biotechnology company ProBioGen has been selected to design, construct, and operate the GMP manufacturing facility at Berlin’s new Centre for Gene and Cell Therapies, establishing a critical infrastructure node for translating advanced therapeutic research into clinical applications across Europe.

